CytoSorbents has won FDA approval to conduct a pivotal trial for the removal of ticagrelor in a cardiopulmonary bypass circuit during urgent and emergent cardiothoracic surgery with the polymer ...

A nonselective extracorporeal blood purification (EBP) device connected to the cardiopulmonary bypass circuit during surgery reduced the risk of cardiac surgery-associated acute kidney injury (CSA-AKI ...

About The Study: The use of a nonselective extracorporeal blood purification device connected to the cardiopulmonary bypass circuit in a nonemergent population of patients undergoing cardiac surgery ...

Unfractionated heparin (UFH), the standard anticoagulant for cardiopulmonary bypass (CPB) surgery, carries a risk of post-operative bleeding and is potentially harmful in patients with heparin-induced ...

Why is this unit important? Successful cardiopulmonary bypass involves the expert utilisation of specialist equipment by the clinical perfusion scientist as part of the cardiac surgical team.

MONMOUTH JUNCTION, N.J., April 20, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to ...

Until the mid-1990s, coronary-artery bypass grafting (CABG) was performed with the use of cardiopulmonary bypass with the induction of ischemic cardiac arrest (on-pump). This surgical approach ...

Please provide your email address to receive an email when new articles are posted on . The cardiac surgery-linked AKI rate was 28.4% among patients on extracorporeal blood purification. The rate was ...

March 14, 2011 — The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists have updated their 2007 blood conservation clinical practice guidelines and have published their ...

The level of familiarity among a cardiac surgical team—including surgeons, anesthesiologists, and perfusionists—does not appear to reduce patient morbidity and mortality but is directly related to ...